
HPLC area purity describes the relative chromatographic response of a peptide sample under a specified method. An assay measures the amount of a defined analyte against an assigned reference. A peptide CDMO specification needs both the result and its reporting basis before a buyer can compare batches or calculate usable material.
Published by Hytanbio Tech. Technical references checked 31 October 2026. Written for B2B material qualification and CDMO project planning.
What does each percentage describe?
Chromatographic purity
An area-normalised HPLC result depends on the peaks detected, the integration rules and the detector response. Water and some other components may contribute little or no response under that method. Co-eluting components can also complicate the result. A certificate showing 98% HPLC area purity therefore does not establish that 100 mg of powder contains 98 mg of the target peptide.
Assay and peptide content
An assay needs a defined measurand: for example, the mass fraction of the target peptide on an as-is basis. Suppliers also use the term peptide content, sometimes for total peptide material after water and counterions are accounted for. Ask whether that term refers to the target sequence, total peptide mass, or a calculated correction. Those meanings produce different purchasing and formulation decisions.
The European Medicines Agency’s synthetic-peptide guideline lists purity, assay, water and counterion controls as separate considerations. Its section 4.4.5 asks for a defined assay calculation and describes a counterion-free, anhydrous basis for LC assay limits unless justified otherwise. The guideline came into effect on 1 June 2026 and concerns synthetic peptides used in medicinal products. Its distinctions are useful when drafting other material specifications, while the applicable requirements depend on the intended use.
Put the reporting basis on the specification
A purchase order that says only “purity ≥98%” leaves several questions unanswered. Ask the laboratory to identify:
- The test method and version, including whether the result is area normalisation or a quantitative assay.
- The chemical form being measured, with counterion identity where relevant.
- The reporting basis: as-is, dried, anhydrous, or another defined basis.
- The reference-standard lot, assigned value and correction used in the calculation.
- Water and residual components measured separately, together with any calculation linking them to the reported value.
FDA’s Q2(R2) guidance treats fitness for intended purpose as the aim of analytical validation. A method suitable for a relative impurity profile may need different evidence from a method used to assign an absolute amount. The laboratory should explain which question each reported result answers.
Compare usable quantity before comparing price
Consider an illustrative calculation with hypothetical values. If 100 mg of supplied powder has an agreed target-peptide assay of 80% on an as-is mass basis, it represents 80 mg of that defined analyte. A separate 98% area-purity result does not replace the 80% assay. It should not be applied again as a correction unless the assay definition explicitly requires it.
For a quote comparison, ask both suppliers to report the same measurand, basis and units. A price per gram of supplied powder and a price per gram of assayed peptide are different commercial offers. Sampling uncertainty, test suitability and the agreed acceptance criteria still need review; a spreadsheet calculation cannot resolve an undefined assay.
Resolve a discrepancy before accepting the batch
- Confirm that the certificate and chromatogram belong to the same batch and sample.
- Compare method versions, standards and reporting bases across the documents.
- Ask for the calculation and the underlying water or counterion results where they are used.
- Record the accepted interpretation in the signed specification and subsequent COA template.
These checks fit alongside the batch traceability review. If two laboratories disagree, the analytical method transfer package can help locate a difference in measurement practice.
For a peptide analytical-testing enquiry, include the proposed assay definition, material form and intended application. Hytanbio reviews the available methods and documentation within the quoted project scope. Current test capabilities and release criteria are confirmed in writing.
Frequently asked questions
Does 99% HPLC purity mean 99% peptide by weight?
No. Area purity measures relative chromatographic response under a method. A mass-based claim needs a defined assay or content measurement and a stated reporting basis.
Should a peptide COA report the counterion?
Where the counterion affects identity, assay interpretation or the intended specification, request its identity and the relevant content control. The requirement and method should be agreed for the material and its intended use.
Can I compare two peptide prices using HPLC purity alone?
HPLC purity alone cannot establish the quantity of the defined peptide in supplied powder. Compare chemical form, assay basis, units, batch evidence and the agreed specification alongside price.
